World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
73
Citations
20746
World Ranking
1644
National Ranking
138

Overview

David Dunn is affiliated with University College London in the United Kingdom. Their research primarily spans the field of Medicine, with a focus on several subfields including Infectious Diseases, Epidemiology, Virology, Psychiatry and Mental Health, as well as Statistics and Probability.

The main areas of their work cover topics related to HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV, Drug Use, and Sexual Risk, as well as HIV/AIDS Drug Development and Treatment. Other significant research interests include Epilepsy Research and Treatment, Statistical Methods in Clinical Trials, and Neonatal and Fetal Brain Pathology.

David Dunn has contributed frequently to the following publication venues:

  • HIV Medicine
  • SSRN Electronic Journal
  • EClinicalMedicine
  • The Lancet HIV
  • AIDS

Notable recent papers authored or coauthored by David Dunn consist of:

  • Safety and immunogenicity of a self-amplifying RNA vaccine against COVID-19: COVAC1, a phase I, dose-ranging trial (2022, EClinicalMedicine)
  • Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia (2021, JAMA)
  • BHIVA guidelines on antiretroviral treatment for adults living with HIV-1 2022 (2022, HIV Medicine)
  • COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 (2023, EClinicalMedicine)
  • Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales (2021, EClinicalMedicine)

The scientist has collaborated extensively with several coauthors, including:

  • Sheena McCormack
  • Leanne McCabe
  • Temitayo Oyegbile-Chidi
  • Jana E. Jones
  • Anna W. Byars

Best Publications

  • Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

    Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling

  • Sources of toxoplasma infection in pregnant women: European multicentre case-control study

    A J C Cook;R E Gilbert;W Buffolano;J Zufferey

  • Risk of human immunodeficiency virus type 1 transmission through breastfeeding

    DT Dunn;ML Newell;AE Ades;CS Peckham

  • Mother-to-Child Transmission of Toxoplasmosis: Risk Estimates for Clinical Counselling

    David Dunn;Martine Wallon;François Peyron;Eskild Petersen

  • Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium

    P. Hagan;U. J. Blumenthal;D. Dunn;A. J. G. Simpson

  • Mother-to-Child Transmission of Hepatitis C Virus: Evidence for Preventable Peripartum Transmission

    D. M. Gibb;R. L. Goodall;D. T. Dunn;M. Healy

  • Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

    Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  • Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study

    Margaret T May;Mark Gompels;Valerie Delpech;Kholoud Porter

  • Risk factors for mother-to-child transmission of HIV-1

    M.L. Newell;D. Dunn;C.S. Peckham;A.E. Ades

  • The epidemiology of HIV-1 infection in urban areas, roadside settlements and rural villages in Mwanza Region, Tanzania.

    Barongo Lr;Borgdorff Mw;Mosha Ff;Nicoll A

  • Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis.

    David Dunn

  • Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.

    D M Gibb;T Duong;P A Tookey;M Sharland

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Morbidity and mortality in European children vertically infected by HIV-1. The French Pediatric HIV Infection Study Group and European Collaborative Study.

    Stéphane Blanche;Marie-louise Newell;Marie-jeanne Mayaux;David T. Dunn

  • Natural history of vertically acquired human immunodeficiency virus-1 infection

    M. L. Newell;C. Peckham;D. Dunn;T. Ades

  • Transmission Network Parameters Estimated From HIV Sequences for a Nationwide Epidemic

    Andrew J. Leigh Brown;Samantha J. Lycett;Lucy Weinert;Gareth J. Hughes

  • Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.

    Patricia Cane;Ian Chrystie;David Dunn;Barry Evans

  • The painful crisis of homozygous sickle cell disease. A study of the risk factors.

    Kenneth F. Baum;David T. Dunn;Gillian H. Maude;Graham R. Serjeant

  • Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

    Marietta Charakida;Ann E. Donald;Hannah Green;Clare Storry

  • The prevention of anaemia in pregnancy in primigravidae in the guinea savanna of Nigeria.

    A. F. Fleming;G. B. S. Ghatoura;K. A. Harrison;N. D. Briggs

  • Molecular phylodynamics of the heterosexual HIV epidemic in the United Kingdom.

    Gareth J. Hughes;Esther Fearnhill;David Dunn;Samantha J. Lycett

Frequent Co-Authors

Caroline Sabin
Caroline Sabin University College London
Deenan Pillay
Deenan Pillay University College London
Andrew N. Phillips
Andrew N. Phillips University College London
Richard Gilson
Richard Gilson University College London
Chloe Orkin
Chloe Orkin Queen Mary University of London
Marie-Louise Newell
Marie-Louise Newell University of Southampton
Martin Fisher
Martin Fisher University of Sussex
Clifford Leen
Clifford Leen Western General Hospital
Diana M. Gibb
Diana M. Gibb University College London
Valerie Delpech
Valerie Delpech Public Health England

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online education options can be a great way to advance your career in microbiology and related fields. For those interested in healthcare, numerous online medical programs offer flexible pathways to earn degrees while balancing work or personal commitments.

Public health is another area closely connected to microbiology. If you're looking for accessible options, consider some of the easy MPH online programs, which provide foundational knowledge in epidemiology and disease control that complements microbiological expertise.

Beyond traditional science roles, careers like child life specialists may appeal to graduates seeking to merge medical knowledge with patient care. Understanding the process to obtain the required CCLS certification can open new pathways in working directly with pediatric patients and families.

It's important to recognize that barriers exist for some prospective students. Those wondering what can a felon go to college for will find that several online degree programs are accessible and designed to support individuals looking to rebuild their careers through education.

By exploring these diverse online degree and certification options, students can tailor their educational journey to meet both professional goals and personal circumstances.

Best Scientists Citing David Dunn

Trending Scientists

Recently Published Articles